Ignite Creation Date:
2024-05-05 @ 5:02 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00378703
Status:
COMPLETED
Last Update Posted:
2018-11-14
First Post:
2006-09-19
Brief Title:
Bevacizumab Sorafenib Tosylate and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2014-02-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-21
Completion Date Type:
ACTUAL
First Submit Date:
2006-09-19
First Submit QC Date:
September 19 2006
Study First Post Date:
2006-09-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-05-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-15
Last Update Post Date:
2018-11-14
Last Update Post Date Type:
ACTUAL